Fiscal Cliff Legislation Extends Alternative Fuels Tax Credits Through 2013

Five Star Equities Provides Stock Research on Archer Daniels Midland and Pacific Ethanol

Continue Reading

Chinese Solar Demand Expected to Grow as China-s Pushes Urbanization Plans

The Paragon Report Provides Stock Research on Canadian Solar and JA Solar

Continue Reading

Gold Posts 12th Consecutive Year of Gains With a 6% Increase in 2012

The Paragon Report Provides Stock Research on Goldcorp and IAMGOLD

Continue Reading

Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and NuPathe

Continue Reading

Machinery Industry on the Upswing as Orders for Capital Goods Show Back-to-Back Monthly Increases

The Paragon Report Provides Stock Research on Manitowoc and Terex

Continue Reading

Renewable Energy and Alternative Fuels Stocks Rally as Deal to Avoid “Fiscal Cliff” Extends Industry Tax Credits

Five Star Equities Provides Stock Research on BioFuel Energy and KiOR

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Impax Laboratories and Spectrum Pharmaceuticals

Continue Reading

Solar Stocks Soar on the Announcement of $2.5 Billion Deal Between SunPower and Warren Buffett-s MidAmerican Energy

The Paragon Report Provides Stock Research on SunPower and First Solar

Continue Reading

Biotech Industry Experiencing More FDA New Drug Approvals in 2012

Five Star Equities Provides Stock Research on Acorda Therapeutics and Peregrine Pharmaceuticals

Continue Reading

Amyris and Solazyme Shares Surge as Alternative Fuels Tax Credit Extended Through 2013

Five Star Equities Provides Stock Research on Amyris and Solazyme

Continue Reading